I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Stathis, Anastasios
129
results:
OpenAccess-fulltext X
Search for persons
X
Sorted by: Relevance
Sorted by: Year
?
1
P1132: LONG-TERM RESPONSES WITH LONCASTUXIMAB TESIRINE: UPD..:
Caimi, Paolo F
;
Ai, Weiyun Z
;
Pablo Alderuccio, Juan
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431093/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
2
PI3Kδ activation, IL6 over-expression, and CD37 loss cause ..:
Arribas, Alberto J
;
Gaudio, Eugenio
;
Napoli, Sara
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680772/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
3
Results of an open-label phase 1b study of the ERK inhibito..:
Stathis, Anastasios
;
Tolcher, Anthony W
;
Wang, Judy S
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289957/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
4
A Phase I Study of the Pan-Notch Inhibitor CB-103 for Patie..:
Hanna, Glenn
;
Stathis, Anastasios
;
López Miranda, Elena
...
Cancer Research Communications;3(9). , 2023
Link:
https://hdl.handle.net/1..
?
5
Targeting myeloid chemotaxis to reverse prostate cancer the..:
Guo, Christina
;
Sharp, Adam
;
Gurel, Bora
...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41586-023-06696-z. , 2023
Link:
https://hdl.handle.net/2..
?
6
Safety and anti-tumor activity of lisavanbulin administered..:
Joerger, Markus
;
Hundsberger, Thomas
;
Haefliger, Simon
...
https://boris.unibe.ch/178871/. , 2023
Link:
https://boris.unibe.ch/1..
?
7
Targeting myeloid chemotaxis to reverse prostate cancer the..:
Guo, Christina
;
Sharp, Adam
;
Gurel, Bora
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686834/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
8
A Phase I Study of the Pan-Notch Inhibitor CB-103 for Patie..:
Hanna, Glenn J
;
Stathis, Anastasios
;
Lopez-Miranda, Elena
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501326/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
9
Genetic and Phenotypic Attributes of Splenic Marginal Zone ..:
Bonfiglio, Ferdinando
;
Bruscaggin, Alessio
;
Guidetti, Francesca
...
info:eu-repo/semantics/altIdentifier/pmid/34653238. , 2022
Link:
http://hdl.handle.net/24..
?
10
Outcome and Prognostic Factors of COVID-19 Infection in Swi..:
Joerger, Markus
;
Metaxas, Yannis
;
Zaman, Khalil
...
info:eu-repo/semantics/altIdentifier/doi/10.3390/cancers14092191. , 2022
Link:
https://archive-ouverte...
?
11
Resistance to PI3Kδ inhibitors in marginal zone lymphoma ca..:
Arribas, Alberto J
;
Napoli, Sara
;
Cascione, Luciano
...
Haematologica. , 2022
Link:
https://ddd.uab.cat/reco..
?
12
Pharmacologic screen identifies active combinations with BE..:
Spriano, Filippo
;
Sartori, Giulio
;
Tarantelli, Chiara
...
info:eu-repo/semantics/altIdentifier/pmid/36051080. , 2022
Link:
https://hdl.handle.net/1..
?
13
In vitro anti-lymphoma activity of the first-in-class pan-N..:
Spriano, Filippo
;
Tarantelli, Chiara
;
Arribas, Alberto J
...
info:eu-repo/semantics/altIdentifier/pmid/36484636. , 2022
Link:
https://hdl.handle.net/2..
?
14
Phase I study of lurbinectedin in combination with weekly p..:
Calvo, Emiliano
;
Sessa, Cristiana
;
Harada, Guilherme
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652263/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
15
SAKK 35/15: a phase 1 trial of obinutuzumab in combination ..:
Stathis, Anastasios
;
Mey, Ulrich
;
Schär, Sämi
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278307/. , 2022
Link:
http://www.ncbi.nlm.nih...
1-15